Breaking News
Get 45% Off 0
🔎 How to spot overhyped stocks (like these) before they drop
Read more

Stock Market Analysis

Contribute
Geoff Considine, Ph.D
Despite Some Concerns, AbbVie Stock Is Still Worth A Look By Geoff Considine, Ph.D - Feb 16, 2022

ABBV faces a significant loss of revenue beginning in 2023 from Humira biosimilars For now, the company is turning in steady earnings growth Wall Street consensus outlook is bullish, but with only 3%...

Fawad Razaqzada
Chart Of The Day: NASDAQ Creaking By Fawad Razaqzada - Feb 12, 2022

Following Thursday’s sharp reversal in the stock markets, the key question is whether we will see any further downside follow-through in this final day of the week, or will dip buyers once again...

Michael Kramer
A Bloodbath In Rates Send Stocks Sharply Lower By Michael Kramer - Feb 11, 2022

Stocks finished lower yesterday after the CPI came in much hotter than expected. Bond yields exploded higher, along with real yields. The move in the bond market was jaw-dropping, with the 2-year rate...

Geoff Considine, Ph.D
Kinder Morgan's Challenging Valuation Suggests Caution By Geoff Considine, Ph.D - Feb 10, 2022

Kinder Morgan provides substantial income, albeit with little expected appreciation Shares are 21% below their pre-COVID 2020 high Wall Street analyst outlook is neutral The market-implied outlook is...

Continue with Apple
Continue with Google
or
Sign up with Email